Physician profile
Samuel Del Rio
NPI 1265497663
$3,114.52
in general payments reported to CMS, 2019-2025
22 companies · $54.52 in 2025
The $54.52 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $560 · 2021: $1,256 · 2022: $256 · 2023: $273 · 2024: $277 · 2025: $54.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.81 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dysis Medical, INC. | $1,099.67 | 2020-2021 | |
| Astellas Pharma US INC | $579.39 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $234.38 | 2019-2022 | |
| Radius Health, INC. | $189.96 | 2019-2024 | Tymlos |
| Millicent US INC | $188.89 | 2019-2024 | Intrarosa, Femring |
| Pfizer INC. | $112.34 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $109.99 | 2023-2025 | Gemtesa, Myfembree |
| Hologic Sales and Service, LLC | $108.86 | 2019-2023 | Thinprep 2000 Processor, Aptima |
| Intuitive Surgical, INC. | $86.49 | 2021 | |
| Mayne Pharma Commercial LLC | $77.16 | 2022-2024 | |
| Therapeuticsmd, INC. | $75.88 | 2019-2020 | |
| Aspira Women'S Health INC | $58.79 | 2019-2022 | |
| Exact Sciences Corporation | $38.63 | 2024 | Cologuard Collection Kit |
| Lupin INC. | $21.53 | 2019 | |
| Evofem Biosciences, INC. | $20.78 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $20.61 | 2020 | |
| Allergan, INC. | $18.89 | 2019 | |
| Medtronic USA, INC. | $17.53 | 2019 | |
| Urovant Sciences INC | $15.93 | 2022 | |
| Agile Therapeutics, INC. | $14.75 | 2021 | |
| Exeltis, USA INC. | $12.24 | 2022 | |
| Avion Pharmaceuticals | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Del Rio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.